Open for inclusion

Randomised phase II trial on primary chemotherapy with high-dose methtrexate and high-dose cytarabine with or without thiotepa, and with or without rituximab, followed by brain irradiation vs. high-dose chemotherapy supported by autologous stem cell trans

Cancer type: Lymphoma

Phase: II

Principal Investigator: Pulczynski Elisa Jacobsen

Country: DK

Keywords: Denmark, Aarhus

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01011920?term=ielsg32&rank=1